![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 02, 2017 8:14:38 AM
My guess on the 11mil $1.10 shares is that we wanted money upfront and the doc wanted some equity ownership.
More likely there was a request for a straight cash payment and the request was denied by the Dr.. The "share purchase" was to throw a bone at CYTR. Basically CYTR got a pittance up-front. This deal for a drug that people on this board believe is valued in the billions...really? If you look at deals made for other promising drugs, that aren't as far along the regulatory path as Aldox there is often a large cash payment upfront.
this might help show what a lousy deal this is for CYTR...
https://www.ft.com/content/e552d59c-f2a4-11e4-b914-00144feab7de
http://www.nature.com/nbt/journal/v33/n7/fig_tab/nbt.3278_T7.html?foxtrotcallback=true
“A bank would never get away with what the Department of Education is doing.”
Sheila Bair
FEATURED Cannabix Technologies to Deliver Innovative Breath Logix Alcohol Screening Device to Texas, USA • Jul 29, 2024 9:07 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM
BNCM AND DELEX UNVEIL POST-MERGER MANAGEMENT PLANS • BNCM • Jul 29, 2024 9:00 AM
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM